AIFM2 and cancer: The phase separation of FSP1 induced by a class of compounds known as 3-phenylquinazolinones (represented by icFSP1) promotes ferroptosis, suggesting that FSP1 inhibition could serve as an effective anti-cancer therapy (Nakamura et al., 2023).